Received Mar 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
got COVID; got COVID; This is a spontaneous report received from a Consumer or other non HCP. A 73-year-old male patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High cholesterol" (unspecified if ongoing); "Blood pressure" (unspecified if ongoing); "pulse" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL taken for blood pressure abnormal, pulse abnormal, start date: 2023 (ongoing); ATORVASTATIN taken for blood cholesterol increased (ongoing). Vaccination history included: Bnt162b2 (DOSE 1), for Covid-19 Immunization, reaction(s): "little reactions"; Bnt162b2 (DOSE 2), for Covid-19 Immunization, reaction(s): "little reactions"; Bnt162b2 (DOSE NUMBER UNKNOWN (BOOSTER)), for Covid-19 Immunization, reaction(s): "little reactions". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2024, outcome "unknown" and all described as "got COVID". The patient reported he had all the boosters and vaccine before (always had COVID vaccine from Pfizer). He then added, that missed one booster and got COVID in Jul2024 and was pretty sick.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500052280 Same reporter, different patient, drug and AE;US-PFIZER INC-202500052080 Same patient, different dose and event;
Medical History/Concurrent Conditions: Blood pressure abnormal; High cholesterol; Pulse abnormal
METOPROLOL; ATORVASTATIN